SE9101086L - Lymphocyte stimulating factor from TRYPANOSOMA BRUCEI - Google Patents

Lymphocyte stimulating factor from TRYPANOSOMA BRUCEI

Info

Publication number
SE9101086L
SE9101086L SE9101086A SE9101086A SE9101086L SE 9101086 L SE9101086 L SE 9101086L SE 9101086 A SE9101086 A SE 9101086A SE 9101086 A SE9101086 A SE 9101086A SE 9101086 L SE9101086 L SE 9101086L
Authority
SE
Sweden
Prior art keywords
stimulating factor
lymphocyte stimulating
trypanosoma brucei
factor
gamma
Prior art date
Application number
SE9101086A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE468250B (en
SE9101086D0 (en
Inventor
Bo Hoejeberg
Conny Edlund
Krister Kristensson
Moiz Bakhiet
Tomas Olsson
Original Assignee
Bo Hoejeberg
Conny Edlund
Krister Kristensson
Moiz Bakhiet
Tomas Olsson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bo Hoejeberg, Conny Edlund, Krister Kristensson, Moiz Bakhiet, Tomas Olsson filed Critical Bo Hoejeberg
Priority to SE9101086A priority Critical patent/SE468250B/en
Publication of SE9101086D0 publication Critical patent/SE9101086D0/en
Priority to PCT/SE1992/000191 priority patent/WO1992018538A1/en
Priority to AU14599/92A priority patent/AU1459992A/en
Publication of SE9101086L publication Critical patent/SE9101086L/en
Publication of SE468250B publication Critical patent/SE468250B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A lymphocyte stimulating factor constituted by a protein having the ability to stimulate, in a living animal body, CD8+ T-cells resulting in release of interferon- gamma (IFN- gamma ) thereby causing immunosuppression in said body; a method of treating African sleeping sickness using such factor; and a monoclonal antibody directed against said factor.
SE9101086A 1991-04-11 1991-04-11 Lymphocyte stimulating factor from TRYPANOSOMA BRUCEI SE468250B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9101086A SE468250B (en) 1991-04-11 1991-04-11 Lymphocyte stimulating factor from TRYPANOSOMA BRUCEI
PCT/SE1992/000191 WO1992018538A1 (en) 1991-04-11 1992-03-25 A lymphocyte stimulating factor originating from the haemoflagellate trypanosoma
AU14599/92A AU1459992A (en) 1991-04-11 1992-03-25 A lymphocyte stimulating factor originating from the haemoflagellate trypanosoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101086A SE468250B (en) 1991-04-11 1991-04-11 Lymphocyte stimulating factor from TRYPANOSOMA BRUCEI

Publications (3)

Publication Number Publication Date
SE9101086D0 SE9101086D0 (en) 1991-04-11
SE9101086L true SE9101086L (en) 1992-10-12
SE468250B SE468250B (en) 1992-11-30

Family

ID=20382432

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9101086A SE468250B (en) 1991-04-11 1991-04-11 Lymphocyte stimulating factor from TRYPANOSOMA BRUCEI

Country Status (3)

Country Link
AU (1) AU1459992A (en)
SE (1) SE468250B (en)
WO (1) WO1992018538A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891439A (en) * 1996-07-26 1999-04-06 Sbl Vaccin Ab, Stockholm, Se Lymphocyte stimulating factor
CN101378777A (en) * 2006-02-07 2009-03-04 日本生物学的制剂有限公司 Novel vaccine carrier

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL62903A0 (en) * 1980-05-22 1981-07-31 Deutsches Krebsforsch Method for the production of interferon ii and stimulated clones for the carrying out of the method

Also Published As

Publication number Publication date
AU1459992A (en) 1992-11-17
SE468250B (en) 1992-11-30
WO1992018538A1 (en) 1992-10-29
SE9101086D0 (en) 1991-04-11

Similar Documents

Publication Publication Date Title
CY1107571T1 (en) NURSING GROWTH FACTOR AS Auxiliary Vaccine
NO933126D0 (en) RELIABLE LIGANDS FOR CD40
DK1266965T3 (en) Recombinant antibodies for human therapy
DE69321030T2 (en) Device for stimulating the heart
NO20001104D0 (en) Humanized antibodies to human gp39, compositions containing such, and therapeutic uses thereof
DE68926859D1 (en) NATURAL KILLER CELL STIMULATION FACTOR
DE69313778T2 (en) Device for stimulating the heart
DK0749323T3 (en) Methods for modulating T cell anergy
GR3029774T3 (en) Method of preparing a radioactive rhenium complex solution.
SE9101086L (en) Lymphocyte stimulating factor from TRYPANOSOMA BRUCEI
DE3884646D1 (en) Human carcinoma-associated antigen and antibodies binding to this antigen.
DK69690A (en) HUMAN ANTI-RH (D) MONOCLONAL ANTIBODIES
DE69327706T2 (en) Device for stimulating the heart
NO883603D0 (en) HUMAN MONOCLONAL ANTIBODIES AND PROPHYLACTIC AND THERAPEUTIC AGENTS FOR INFECTIOUS DISEASES INCLUDING THESE EFFECTIVE COMPONENT.
IL83584A0 (en) Monoclonal antibodies against glycosylated human albumin,method and immunogens for raising said antibodies and their use in immunoassays
RU95110653A (en) Agent stimulating immunoglobulin synthesis in experiment
RU96123906A (en) METHOD AND VACCINE FOR PREVENTION AND TREATMENT OF IMMUNO DEFICIENCIES, FOR EXAMPLE CANCER
DK0542895T3 (en) Cross-reactive influenza A immunization
FR2684518B1 (en) SELF-LOCKING DEVICE FOR THE IMMOBILIZATION OF SHEEP, CATTLE, GOAT ANIMALS FOR MILKING, FEEDING, SORTING AND PROCESSING.
GB2233559B (en) Antibodies for use in antilymphocyte antibody therapy
ATA123988A (en) LUNG TREATMENT DEVICE FOR HUMAN OR ANIMAL LUNG
BR8306869A (en) MECHANICAL HEART VALVE IMPLANTABLE IN HUMAN BEINGS
BR8306870A (en) MECHANICAL HEART VALVE IMPLANTABLE IN HUMAN BEINGS
RU93040876A (en) APPLICATION OF THE PEPTIDE PHE-LEU-GLY-PHE-PRO-THR AS AN IMMUNO-REGULATORY ACTIVITY SUBSTANCE
LV5784B4 (en) Human growth necrosis factor monoclonal antibodies

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 9101086-8

Format of ref document f/p: F

NUG Patent has lapsed